A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004)

NCT01015677 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Vasomotor Symptoms in Postmenopausal
Women

Interventions

DRUG: MK-6913
DRUG: 17-β estradiol
DRUG: Placebo to MK-6913
DRUG: Placebo to 17-β estradiol
DRUG: MK-6913 25 mg

Sponsor

Merck Sharp & Dohme LLC